Ascorbic Acid [clinicaltrials_resource:6f276e8079ee87584f66bee05901e7ab]
Women's Angiographic Vitamin and Estrogen Trial (WAVE) [clinicaltrials:NCT00000555]The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients [clinicaltrials:NCT00001070]The Body's Affect on Vitamin C [clinicaltrials:NCT00001309]Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [clinicaltrials:NCT00006021]A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV Drugs [clinicaltrials:NCT00037063]Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma [clinicaltrials:NCT00085345]Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma [clinicaltrials:NCT00112879]clinicaltrials:NCT00117403Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients? [clinicaltrials:NCT00172302]clinicaltrials:NCT00184054clinicaltrials:NCT00227682Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers [clinicaltrials:NCT00231218]clinicaltrials:NCT00258245clinicaltrials:NCT00270647clinicaltrials:NCT00271635Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals. [clinicaltrials:NCT00272428]clinicaltrials:NCT00274820Safety of Antioxidants During GYN Cancer Care [clinicaltrials:NCT00284427]Prophylactic Administration of Vitamin C in Wrist Fractures [clinicaltrials:NCT00296868]MOVIPREP® Versus PICOLAX® Pilot Study [clinicaltrials:NCT00312481]Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma [clinicaltrials:NCT00317811]Clinical Evaluation of a New Reduced Volume Bowel Preparation [clinicaltrials:NCT00321230]MOVIPREP® Versus NaP Pivotal Phase III Study [clinicaltrials:NCT00322062]Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism [clinicaltrials:NCT00325572]L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes [clinicaltrials:NCT00329498]clinicaltrials:NCT00350077NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization [clinicaltrials:NCT00356954]Vitamins C and Vitamin E and Cardiovascular Risk [clinicaltrials:NCT00362518]A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution [clinicaltrials:NCT00389233]A Phase 2 Study of the Effects of 6R-BH4 on Symptomatic Peripheral Arterial Disease [clinicaltrials:NCT00403494]Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening [clinicaltrials:NCT00427089]Study of High-Dose Intravenous (IV) Vitamin C Treatment in Patients With Solid Tumors [clinicaltrials:NCT00441207]clinicaltrials:NCT00469209clinicaltrials:NCT00484510Clinical Utility of Endothelial Dysfunction in PAD [clinicaltrials:NCT00491751]clinicaltrials:NCT00519337A Phase 2, Pharmacokinetic Study of the Effects of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction [clinicaltrials:NCT00532844]Vitamin C and Cardiovascular Risk [clinicaltrials:NCT00534014]Effect of Grape Seed Extract Plus Ascorbic Acid on Endothelial Function [clinicaltrials:NCT00554242]Effect of Supplementary Vitamins on Oxidant Gene Expression in the Lungs of Healthy Smokers [clinicaltrials:NCT00565214]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Ascorbic Acid [clinicaltrials_resource:6f276e8079ee87584f66bee05901e7ab]
Bio2RDF identifier
6f276e8079ee87584f66bee05901e7ab
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6f276e8079ee87584f66bee05901e7ab
identifier
clinicaltrials_resource:6f276e8079ee87584f66bee05901e7ab
title
Ascorbic Acid
@en
type
label
Ascorbic Acid [clinicaltrials_resource:6f276e8079ee87584f66bee05901e7ab]
@en